IHS Chemical Week

World News and Views :: Top of the News

Novozymes acquires Allopartis Biotechnologies

4:02 PM MDT | October 23, 2013 | Natasha Alperowicz

Novozymes has acquired Allopartis Biotechnologies (San Francisco) from CalCEF Clean Energy Angel Fund I (San Francisco) for an undisclosed sum. Allopartis, founded in 2008, specializes in screening enzymes for industrial use. CalCEF Clean Energy Angel Fund I is a seed and early-stage venture capital fund focusing entirely on emerging, transformative technology in the clean energy markets. It made its first investment in Allopartis in September 2008, along with XSeed Capital, the company says.   “Novozymes looks forward to integrate and...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa